- Home
- LFMD vs ARVN Comparison
LFMD vs ARVN Comparison
Compare LFMD & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFMD
- ARVN
- Stock Information
- Founded
- LFMD 1994
- ARVN 2015
- Country
- LFMD United States
- ARVN United States
- Employees
- LFMD N/A
- ARVN N/A
- Industry
- LFMD Medical/Nursing Services
- ARVN Biotechnology: Pharmaceutical Preparations
- Sector
- LFMD Health Care
- ARVN Health Care
- Exchange
- LFMD Nasdaq
- ARVN Nasdaq
- Market Cap
- LFMD 535.4M
- ARVN 456.2M
- IPO Year
- LFMD N/A
- ARVN 2018
- Fundamental
- Price
- LFMD $6.17
- ARVN $7.90
- Analyst Decision
- LFMD Buy
- ARVN Buy
- Analyst Count
- LFMD 6
- ARVN 22
- Target Price
- LFMD $12.50
- ARVN $20.21
- AVG Volume (30 Days)
- LFMD 2.7M
- ARVN 1.9M
- Earning Date
- LFMD 08-05-2025
- ARVN 10-29-2025
- Dividend Yield
- LFMD N/A
- ARVN N/A
- EPS Growth
- LFMD N/A
- ARVN N/A
- EPS
- LFMD N/A
- ARVN N/A
- Revenue
- LFMD $245,563,670.00
- ARVN $372,800,000.00
- Revenue This Year
- LFMD $21.50
- ARVN $4.87
- Revenue Next Year
- LFMD $17.41
- ARVN N/A
- P/E Ratio
- LFMD N/A
- ARVN N/A
- Revenue Growth
- LFMD 37.74
- ARVN 299.57
- 52 Week Low
- LFMD $3.99
- ARVN $5.90
- 52 Week High
- LFMD $15.84
- ARVN $29.61
- Technical
- Relative Strength Index (RSI)
- LFMD 33.02
- ARVN 60.55
- Support Level
- LFMD $5.95
- ARVN $6.96
- Resistance Level
- LFMD $6.54
- ARVN $8.22
- Average True Range (ATR)
- LFMD 0.32
- ARVN 0.32
- MACD
- LFMD 0.13
- ARVN 0.11
- Stochastic Oscillator
- LFMD 23.40
- ARVN 78.38
About LFMD LifeMD Inc.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
About ARVN Arvinas Inc.
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.